Nasopharyngeal swab in Viral or Universal Transport Media
Specimen Preparation
1. Label specimen with Cerner label (if available)
2. Place each specimen in individual biohazard bag
3. Place absorbent material in bag with specimen (do NOT wrap)
4. Place bagged specimen in a 2nd biohazard bag
5. Label as PUI (Patient Under Investigation)
6. Place extra labels, requisition forms and/or transfer lists in the outside bag pocket
7. Hand deliver to laboratory
Unacceptable Conditions
Mislabeled, improperly transported or handled, sample leaking from tube or showing signs of potential contamination
Stability (from collection to initiation)
Room temperature (15-30oC) up to 24 hours. Refrigerated (2-8oC) up to 7 days.
BayCare Hospital Laboratory - 7 days/week
Turn around time ~1-2 hours
Ordering Recommendations
This test is not available in PowerChart, it is to be used for urgent cases only when a same day discharge to a SNF or an ALF is needed; please coordinate with Case Management or Infection Prevention.
Methodology
Cepheid (manufacturer). This assay is based on PCR (Polymerase Chain Reaction) and it targets the N2 gene and E gene of the virus.
LOD (Limit of Detection) is ~50-100 copies/mL [verified in lab, limited studies]
This assay is approved by the FDA as EUA (Emergency Use Authorization)
Synonyms
Coronavirus
SARS-CoV-2
Reference Interval
Negative
Interpretive Data
A Positive result indicates that RNA from SARS-CoV-2 (formerly 2019-nCoV) was detected, and that the patient is considered infected with the virus and presumed to be contagious.
A Negative test result indicates that SARS- CoV-2 RNA was not detected. Negative results should be interpreted in combination with clinical observations and patient history.
An Invalid result indicates an inadequate specimen or incomplete detection of targets. Repeat testing is being performed with an alternate method.
Collection
Collect
Nasopharyngeal swab in Viral or Universal Transport Media
Specimen Preparation
1. Label specimen with Cerner label (if available)
2. Place each specimen in individual biohazard bag
3. Place absorbent material in bag with specimen (do NOT wrap)
4. Place bagged specimen in a 2nd biohazard bag
5. Label as PUI (Patient Under Investigation)
6. Place extra labels, requisition forms and/or transfer lists in the outside bag pocket
7. Hand deliver to laboratory
Unacceptable Conditions
Mislabeled, improperly transported or handled, sample leaking from tube or showing signs of potential contamination
Stability (from collection to initiation)
Room temperature (15-30oC) up to 24 hours. Refrigerated (2-8oC) up to 7 days.
BayCare Hospital Laboratory - 7 days/week
Turn around time ~1-2 hours
Ordering Recommendations
This test is not available in PowerChart, it is to be used for urgent cases only when a same day discharge to a SNF or an ALF is needed; please coordinate with Case Management or Infection Prevention.
Methodology
Cepheid (manufacturer). This assay is based on PCR (Polymerase Chain Reaction) and it targets the N2 gene and E gene of the virus.
LOD (Limit of Detection) is ~50-100 copies/mL [verified in lab, limited studies]
This assay is approved by the FDA as EUA (Emergency Use Authorization)
Synonyms
Coronavirus
SARS-CoV-2
Result Interpretation
Reference Interval
Negative
Interpretive Data
A Positive result indicates that RNA from SARS-CoV-2 (formerly 2019-nCoV) was detected, and that the patient is considered infected with the virus and presumed to be contagious.
A Negative test result indicates that SARS- CoV-2 RNA was not detected. Negative results should be interpreted in combination with clinical observations and patient history.
An Invalid result indicates an inadequate specimen or incomplete detection of targets. Repeat testing is being performed with an alternate method.
